

























































Surface Display of Complex Enzymes by in Situ SpyCatcher-
SpyTag Interaction
Sabrina Gallus,[a] Theo Peschke,[a, b] Malte Paulsen,[c] Teresa Burgahn,[a] Christof M. Niemeyer,[a]
and Kersten S. Rabe*[a]
The display of complex proteins on the surface of cells is of
great importance for protein engineering and other fields of
biotechnology. Herein, we describe a modular approach, in
which the membrane anchor protein Lpp-OmpA and a protein
of interest (passenger) are expressed independently as genet-
ically fused SpyCatcher and SpyTag units and assembled in situ
by post-translational coupling. Using fluorescent proteins, we
first demonstrate that this strategy allows the construct to be
installed on the surface of E. coli cells. The scope of our
approach was then demonstrated by using three different
functional enzymes, the stereoselective ketoreductase Gre2p,
the homotetrameric glucose 1-dehydrogenase GDH, and the
bulky heme- and diflavin-containing cytochrome P450 BM3
(BM3). In all cases, the SpyCatcher-SpyTag method enabled the
generation of functional whole-cell biocatalysts, even for the
bulky BM3, which could not be displayed by conventional
fusion with Lpp-OmpA. Furthermore, by using a GDH variant
carrying an internal SpyTag, the system could be used to
display an enzyme with unmodified N- and C-termini.
The presentation of peptides and proteins on the surface of
bacterial cells is essential for their interaction with the
environment.[1–2] In biotechnology, this process has been
exploited for applications in protein library screening,[3–4] the
production of recombinant bacterial vaccines[5] or biosensors,[6]
and it is also used as a powerful tool for the generation of
whole-cell biocatalysts.[6–7] In the latter case, the employment of
microorganisms instead of purified enzymes as biocatalysts can
circumvent cost-intensive enzyme production and purification
as well as simplify production processes. Compared to conven-
tional whole-cell biocatalysis using intracellular enzymes, the
presentation of enzymes on the cell surface can largely reduce
mass transfer limitations by eliminating the need of substrates
or products to cross the cell envelope. This can open up ways
for processing of membrane-impermeable small molecules,
which account for a large proportion of pharmaceutically and
industrially relevant compounds.
Common systems for the display of proteins on E. coli cells
are based on genetic fusions of the protein of interest
(passenger) to a membrane anchor that facilitates the transport
across the cell envelope and anchors the passenger in the
bacterial outer membrane. In the past decades a large number
of membrane anchors have been developed.[6–9] Impressive
examples of the successful surface display of demanding
enzymes include the homotetrameric glucose 1-
dehydrogenase[10] as well as the cofactor containing enzymes
alditol oxidase[11] or the bulky cytochrome P450 BM3
monooxygenase[12–14] using membrane anchors such as INP[15] or
AIDA-I.[16] However, successful surface display of a given
passenger is highly dependent on special features of the
membrane anchor such as the potential fusion site with the
passenger (N-terminal, C-terminal or internal) or the compati-
bility with the passenger's three-dimensional structure within
the genetic fusion. Incompatible combination of membrane
anchors and passenger proteins can lead to unfavourable
domain interactions, misfolding of the fusion protein, degrada-
tion or even complete loss of functionality, thus strongly
effecting surface display efficiency and whole-cell activities.[17]
Recently, so-called post-translational bioconjugation meth-
ods are being investigated for the modular assembly of protein
constructs that cannot be generated directly by genetic fusion.
The SpyCatcher-SpyTag bioconjugation system, consisting of
the 113 amino acid SpyCatcher (SC) protein and the 13 amino
acid SpyTag (ST) peptide,[18] is a powerful method that has been
employed for this purpose.[19–20] SC and ST form a covalent
isopeptide bond between a proximal aspartic acid and lysine
residue, thereby enabling the covalent coupling of correctly
folded proteins that are independently expressed as genetic
fusions with the SC and ST domains. The SC-ST coupling occurs
over a wide range of physiological conditions, does not require
reagents and has therefore also been applied for in vivo
applications inside bacterial cells.[21–26]
To extend the toolbox for surface display of complex, high
molecular weight enzymes on E. coli cells, we here report on
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the investigation of a novel modular surface display method in
which the membrane anchor and the passenger are expressed
separately and assembled by post-translational bioconjugation
via SC-ST coupling (Figure 1). As this allows independent
folding of the anchor and passenger proteins, we reasoned that
our approach might reduce unfavourable domain interactions
and misfolding, thereby increasing the display efficiency and
the whole-cell biocatalytic activity. To demonstrate the func-
tionality and utility of our approach we chose the well-
established Lpp-OmpA hybrid as a model membrane anchor.[27]
This anchor consists of the transmembrane domain (amino
acids 46-159) from outer membrane protein A (OmpA) as well
as the signal peptide and the first 9 N-terminal amino acids of
the E. coli lipoprotein (Lpp). Lpp-OmpA has already been used
for stable membrane anchoring of functional enzymes fused to
its C-terminus[28–31] but, like many others, seems to be limited in
terms of passenger size.[17]
As illustrated in Figure 1, our SC-ST display system is
comprised of the membrane anchor Lpp-OmpA genetically
fused to a SC domain, while the passenger is fused to the
smaller ST to minimize possible interactions during folding of
complex large enzyme passengers. Expression of both compo-
nents takes place separately and covalent interaction occurs by
post-translational SC-ST isopeptide bond formation. Anchoring
of the ligated complex into the E. coli outer membrane is
mediated by Lpp-OmpA to facilitate surface display of the
passenger. As previous studies indicated that the expression of
Lpp-OmpA fusions from high copy number plasmids employing
a leaky promoter led to slow growth, altered membrane
integrity or even cell lysis,[29,32–33] all Lpp-OmpA fusions were
expressed from a medium copy number pTF16 derived plasmid
employing a p15A ori, an ampicillin resistance gene and the
tight l-arabinose-inducible araB promoter.[24,34] A fully orthogo-
nal pET derived plasmid with pBR322 ori, using an independent
replication mechanism and employing a chloramphenicol
resistance gene, was chosen as the second plasmid to ensure
plasmid stability and to allow for controlled induction of the
passenger-ST via an IPTG inducible T7 promoter. A detailed
presentation of the construct design is shown in Figure S1 in
the Supporting Information.
To examine the functionality of the modular SC-ST surface
display, we first investigated on the formation and integration
of the SC-ST complex into the cell envelope using fluorescent
anchor and passenger modules (Figure 2). To this end, ST was
fused to the monomeric red fluorescent protein mRFP and the
Lpp-OmpA-SC fusion was modified with eGFP. Functional
interaction of mRFP-ST with Lpp-OmpA-eGFP-SC and subse-
quent translocation to the cell surface was expected to result in
a co-localization of mRFP and eGFP fluorescence signals in the
cell envelope. Confocal fluorescence microscopy imaging in-
deed allowed to detect both fusion proteins in the outer areas
of E. coli, thus indicating successful covalent interaction and
translocation to the cell envelope (Figure 2A). As expected,
controls in which expression of Lpp-OmpA-eGFP-SC was not
induced showed no such co-localization (Figure 2B). Treatment
of the cells with proteinase K, which cannot penetrate intact
cells, degraded the SC-ST complex as revealed by western blot
analysis (Figure S2), thereby confirming the surface accessibility
of the complex. To ensure that the surface presentation is not a
result of intercellular cross-coupling events, in which the
passenger leaks into the medium and subsequently couples to
surface presented Lpp-OmpA-SC fusions of neighbouring cells,
additional experiments were performed with co-cultured cells
presenting mRFP or eGFP on their surface (Figure S3). As we
could only detect cells with either mRFP or eGFP fluorescence
but no cells that show the fluorescent signals of both mRFP and
eGFP, we concluded that no cross-coupling occurs and that the
SC-ST interaction takes place inside the cell before translocation
of the complex to the cell surface.
To investigate the applicability of our system for the surface
display of active enzymes, we chose the monomeric (S)-
selective methylglyoxal reductase Gre2p (EC 1.1.1.283) from
Saccharomyces cerevisiae YJM193[35] as well as the more
complex homotetrameric glucose 1-dehydrogenase (GDH) (EC
1.1.1.47) from Bacillus subtilis[36] and a variant of the bulky
(119 kDa) heme- and diflavin-containing cytochrome P450 BM3
monooxygenase (BM3) from Bacillus megaterium (CYP102 A1,
EC 1.14.14.1) as passengers.[37] Surface display of the two latter
ones has so far only been reported using more recently
established membrane anchors such as INP or AIDA-I.[10,12–14] We
initially demonstrated that covalent interaction of the three
passenger-ST fusions with Lpp-OmpA-SC can be precisely
controlled by the induction of the expression of Lpp-OmpA-SC
Figure 1. Concept of the E. coli surface display based on post-translational
SC-ST coupling. The membrane anchor Lpp-OmpA is genetically fused to a
SC domain, while the passenger is fused to the smaller ST. Subsequent to
expression from individual plasmids, the fusion proteins covalently couple
through a specific SC-ST interaction. The complex is anchored in the E. coli
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as verified in whole-cell lysates using western blot analysis
(Figure S4). We then confirmed the surface exposure of the
functional passengers via their activity in whole-cell biocatalytic
assays. To this end, whole cells that were supposed to display
the biocatalyst on their surface were incubated with substrates
and cofactors, with at least one not being able to penetrate the
cell membrane and the enzymatic activity was determined by
fluorescence read-outs (Figure 3, for details on the enzymatic
reactions employed see Figure S5). Control cells expressing the
passenger-ST fusions intracellularly only converted the selected
substrates upon permeabilization with toluene (Figure S6A),
thereby confirming that the substrates were indeed not able to
penetrate into intact cells. Compared to these control cells, the
conversion was significantly increased, when the passenger-ST
fusions were targeted to the cell surface via the expression of
Lpp-OmpA-SC, as indicated in Figure 3B. These results gave a
clear indication that the SC-ST surface display system can be
used to effectively anchor the passenger on the cells, thereby
reducing mass transfer limitations between the enzymes and
the surrounding medium. The permeabilization of the cells
further increased the conversion rates (Figure S6B), presumably
because excess passenger-ST fusions that were not coupled to
Lpp-OmpA-SC (Figure S4) remain in the cytosol of the cells and
Figure 2. The passenger mRFP carrying a ST interacts with Lpp-OmpA-eGFP-SC and is translocated to the E. coli cell envelope. E. coli cells harboring plasmids
pET_mRFP-ST and pTF16_Lpp-OmpA-eGFP-SC were either A) induced with IPTG and l-arabinose for translocation of mRFP-ST to the cell surface after covalent
interaction with Lpp-OmpA-eGFP-SC or B) induced with only IPTG for cytosolic expression of mRFP-ST. Fluorescence microscopy pictures were taken 6 h after
induction. Scale bars of magnified insets: 1 μm.
Figure 3. Display of ST-modified passenger enzymes by post-translational conjugation to Lpp-OmpA-SC leads to a strong increase in the conversion rates for
membrane impermeable substrates or cofactors. A) Schematic representation of whole-cell biocatalytic activity assays; details are given in Figure S5. B) Cells in
which the passenger enzymes Gre2p-ST, GDH-ST or BM3-ST are targeted to the cell surface by the expression of Lpp-OmpA-SC (+Lpp-OmpA-SC, black bars)
show significantly increased whole-cell biocatalytic activities, as compared to cells expressing the passenger-ST fusions intracellularly (  Lpp-OmpA-SC, grey
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can contribute to the activity of the biocatalyst after permeabi-
lization.
It was observed in previous studies that high-level expres-
sion of Lpp-OmpA fusions can cause substantial alterations in
the E. coli outer membrane permeability.[32–33] Due to this
phenomenon, and because we observed irregular cell shapes
upon longer induction times (Figure S7), we suspected that the
above described increase in whole-cell biocatalytic activity
might not be completely conclusive to prove the passenger
localization on the cell surface. We therefore carried out
additional experiments to investigate the membrane integrity.
To this end, we determined the whole-cell biocatalytic activity
of a control sample overexpressing non-coupling Lpp-OmpA-ST
in the outer membrane and BM3-ST in the cytosol (non-
coupling control, see Figure S8). We found modest conversion
of the substrate, suggesting that the overexpression of Lpp-
OmpA fusions from the pTF16 derived vector leads to increased
permeability of the E. coli outer membrane, thereby allowing
the diffusion of substrates and cofactors into the cell and their
subsequent conversion in the cytosol. These alterations in
membrane integrity are presumably caused by the all-or-none
response of the l-arabinose inducible araB promoter used to
control the expression of Lpp-OmpA fusions in this study.
According to Siegele et al.[38] the l-arabinose concentration in
the medium influences the number of fully induced cells rather
than adjusting the expression level in individual cells. This leads
to a high-level expression of Lpp-OmpA fusions in the induced
cells, which might cause an altered membrane permeability, as
reported previously.[32–33] However, since permeabilization of the
cells by addition of toluene led to a strong further increase in
the conversion rate (Figure S8), the membrane barrier does not
seem to be completely disrupted. Owing to the observed
changes in membrane permeability, the whole-cell biocatalytic
activity assays could not be used as a firm proof for the surface
localization of passenger enzymes. To further investigate the
passenger localization at the cellular level, we therefore carried
out immunofluorescence microscopy studies. To this end, cells
displaying BM3-ST modified with a C-terminal Myc epitope tag
were incubated with a fluorescently labelled anti-Myc antibody
(Figure 4). We found that cells displaying BM3 with the SC-ST
display system clearly turned fluorescent (Figure 4B). Due to the
above discussed observation that the membrane integrity was
compromised by the overexpression of the membrane anchor,
we confirmed that the antibody could not penetrate into the
cytosol of the cells by employment of a non-coupling control
with membrane integrated Lpp-OmpA-ST and cytosolic BM3-
ST-Myc. As expected, almost no fluorescence was detected for
these control cells (Figure 4B). Altogether, the results gave clear
evidence for the surface presentation of BM3 using the SC-ST
display system. Since immunofluorescence microscopy proved
to be a reliable method for the detection of surface presenta-
tion, similar experiments carried out with the Gre2p-ST and
GDH-ST passenger enzymes demonstrated the successful sur-
face presentation of these enzymes (Figure S9).
Next, we investigated whether the SC-ST display system
offers the expected advantages over conventional display
systems in terms of increased display efficiency. To this end, we
constructed the direct genetic fusion Lpp-OmpA-BM3-Myc. To
ensure comparability regarding the expression levels of the
membrane anchor, this fusion protein was also expressed from
the pTF16 vector (Figure S1C). As demonstrated by immuno-
fluorescence microscopy using the anti-Myc antibody (Fig-
ure 4C), no fluorescent cells were detected. This observation
was confirmed by flow cytometry analysis (Figure S10A),
revealing only a very weak fluorescence for 2.4% of the E. coli
population expressing the Lpp-OmpA-BM3-Myc fusion. In
contrast the cells displaying the passenger with the SC-ST
system showed a much higher fluorescence, which was also
present in a much larger proportion (12.4%) of the population.
A reduced viability was determined for cells that successfully
displayed the passenger, presumably resulting from the
observed alterations in membrane integrity (Figure S10B).
Figure 4. Verification of BM3 surface exposure by means of immunofluorescence microscopy. A) BM3 fusions modified with a C-terminal Myc epitope tag
were detected by using an anti-Myc antibody conjugated to DyLight488. B) Cells presenting BM3-ST with the SC-ST display system were successfully stained
with the antibody, whereas cells employing the corresponding non-coupling control with membrane integrated Lpp-OmpA-ST and cytosolic BM3-ST showed
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Nevertheless, the results clearly indicate that BM3 indeed could
only be displayed using Lpp-OmpA when employing the SC-ST
display system. Based on SDS-PAGE and western blot analyses
(Figure S11A), as well as whole-cell biocatalytic activity meas-
urements (Figure S11B), wherein no substrate conversion was
detected for the conventional display system even when the
cells were permeabilized by addition of toluene, it is evident
that these observations were due to absent expression of the
Lpp-OmpA-BM3 fusion. In fact, these results are in line with
previously published work suggesting that the applicability of
the membrane anchor Lpp-OmpA is limited in terms of
passenger size.[17] Hence, the results clearly confirm the
advantages of the post-translational assembly of separately
folded membrane anchors and passengers. We hypothesize
that this improvement is due to avoidance of possible
unfavourable domain interactions that might occur when the
bulky passenger is directly fused to Lpp-OmpA. In contrast SC
and ST are smaller and stable modifications, which allow for
both the membrane anchor and the passenger to be folded in
the most native way possible, thereby reducing misfolding and
degradation.
As previous studies demonstrated that ST remains func-
tional when fused to the N-terminus, C-terminus or even into
internal loops of a protein of interest,[18,39] we reasoned that our
system might also be able to display passenger enzymes
carrying an internal ST. We therefore constructed a variant of
the passenger enzyme GDH carrying the ST sequence inserted
into an internal flexible loop (GDH(ST), Figure S12). As verified
by immunofluorescence microscopy (Figure 5A), the GDH(ST)
variant was successfully displayed on E. coli. Furthermore, the
surface displayed GDH(ST) variant shows similar levels of
substrate conversion (Figure 5B) as compared to the GDH-ST
variant carrying a C-terminal ST (compare Figure 3B). These
results clearly illustrate that the herein developed display
system can also be used with an internal ST, thereby enabling
the display of passenger enzymes with native N- and C-termini.
To the best of our knowledge, this is not possible with any
other surface display system reported so far.
In conclusion we have reported on a novel approach that
enables surface display of functional, complex enzymes on E.
coli. As demonstrated by whole-cell biocatalytic activity assays
and immunofluorescence microscopy, the herein described
post-translational SC-ST mediated coupling of passenger en-
zymes and the model membrane anchor Lpp-OmpA allowed
successful surface display of the enzymes Gre2p, the homote-
trameric GDH and the highly demanding heme- and diflavin-
containing BM3. The resulting whole-cell biocatalysts revealed
high conversion rates for membrane impermeable substrates,
thereby suggesting substantially reduced mass transfer limita-
tions as compared to cytosolic expression. The observed
alterations in outer membrane permeability and cell viability,
induced by the l-arabinose controlled overexpression of Lpp-
OmpA, might be avoided by optimizing the amount of Lpp-
OmpA in the cell membrane, for instance, by using an
expression system that offers a more gradual modulation of
induction. Since Lpp-OmpA-SC is presumably translocated to
the periplasm via the Sec machinery due to the Lpp
peptide,[40–43] but can obviously interact with the passenger-ST
fusions in the cytosol, we hypothesize that during lipid
modification of the N-terminal Lpp domain at the inner
membrane[41–43] the hydrophobic OmpA domain might get
incorporated into the lipid bilayer with the C-terminal SC
domain being exposed towards the cytoplasm, allowing the
covalent binding of the passenger-ST fusions with subsequent
Figure 5. Surface display of a GDH variant carrying an internal ST. A) Successful surface display of GDH(ST) employing a His6 tag was verified by
immunofluorescence microscopy using an anti-His6 antibody conjugated to AlexaFluor488. Cells presenting the passenger on their surface employing the SC-
ST display system clearly turned fluorescent, whereas the corresponding non-coupling control showed almost no fluorescence. Scale bars:10 μm. B) Surface
display of GDH(ST) after expression of Lpp-OmpA-SC (+Lpp-OmpA-SC, black bars) significantly increased the whole-cell biocatalytic activity, as compared to
cells expressing GDH(ST) intracellularly (  Lpp-OmpA-SC, grey bars). Note that the GDH(ST) displaying cells showed similar levels of substrate conversion, as
compared to cells displaying the GDH-ST variant (C-terminal tag, compare Figure 3B). The whole-cell biocatalytic activity measurement was carried out as in
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translocation to the outer membrane, as reported for the native
Lpp lipoprotein.[41–43] Due to the fast and covalent binding of
the SC-ST system such processes could be studied in more
detail especially when combined with super-resolution micro-
scopy. Other than the conventional direct genetic fusion to
Lpp-OmpA, which results in no detectable expression of the
passenger, the successful BM3 display by aid of our SC-ST
system clearly indicates the advantages of this approach. We
assume that the improved performance is due to reduced
misfolding and degradation. Furthermore, the flexibility in
design of the passenger-ST fusion (N-terminal, C-terminal or
even internal ST) allows the display system to be easily adjusted
to the individual needs of the passenger. This could be
particularly useful for enzymes that do not tolerate genetic
fusions to specific termini. Since the system uses completely
orthogonal expression plasmids for membrane anchor-SC and
passenger-ST fusions, it also enables a combinatorial screening,
without the need to generate each individual genetic fusion.
Based on these arguments, we believe that our approach will
expand the toolbox for efficient presentation of delicate
enzymes on bacterial cell surfaces, thereby further contributing
to the development of productive whole-cell biocatalysts.
Experimental Section
Experimental Details about plasmid construction, amino acid
sequences and experimental procedures are given in the Support-
ing Information.
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